Register for our free email digests:
Division of Masimo Corp.
Latest From Quintiles Inc.
Dianbo Liu, chairman of the Hong Kong listed Luye Group, talks about the company’s ambitious plans to become a global top 100 pharmaceutical company through innovation, acquisitions and overseas expansion, and to broaden its activities well beyond selling medicines to meet changing patient needs and industry pressures.
Biopharma executives were hammered on drug pricing during the JP Morgan conference in January; now they've back in San Francisco and appear prepared to strike back with a united message: all stakeholders must work together.
Scrip spoke with several executives and attended multiple panel discussions in San Francisco during the first full day of BIO's annual international gathering. Drug pricing and enabling innovation emerged as key themes.
Werner Lanthaler talks to Jo Shorthouse about partnering with big pharma on drug discovery, remaining authentic, and creating the 'half pregnant' company that Evotec is today.
- Monitoring Equipment & Devices
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Masimo Corp.
- Senior Management
Robert Zyzanski, CEO
Ola Conrad, CFO
Anders Eckerbom, R&D Mgr.
- Contact Info
Phone: 8 544 98 150
Danderyd, SE-182 33
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.